The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

OraSure Technologies Inc

Nasdaq: OSUR
Last

(U.S.) $4.94

Today's change-0.12 -2.37%
Updated July 31 4:00 PM EDT. Delayed by at least 15 minutes.
 

OraSure Technologies Inc

Nasdaq: OSUR
Last

(U.S.) $4.94

Today's change-0.12 -2.37%
Updated July 31 4:00 PM EDT. Delayed by at least 15 minutes.

OraSure Technologies Inc down (U.S.)$0.12

OraSure Technologies Inc closed sharply lower Friday, dropping (U.S.)$0.12 or 2.37% to (U.S.)$4.94. Over the last five days, shares have lost 1.98% and are down 51.28% for the last year to date. This security has underperformed the S&P 500 by 48.95% during the last year.

Key company metrics

  • Open(U.S.) $5.03
  • Previous close(U.S.) $5.06
  • High(U.S.) $5.03
  • Low(U.S.) $4.85
  • Bid / Ask-- / --
  • YTD % change-51.28%
  • Volume743,338
  • Average volume (10-day)565,194
  • Average volume (1-month)603,701
  • Average volume (3-month)1,118,575
  • 52-week range(U.S.) $4.42 to (U.S.) $10.93
  • Beta1.63
  • Trailing P/E259.86×
  • P/E 1 year forward233.18×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.02
Updated July 31 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.60%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue27292826
Total other revenue--------
Total revenue27292826
Gross profit17181916
Total cost of revenue1011910
Total operating expense27312724
Selling / general / administrative14171516
Research & development3433
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--00-6
Other operating expenses, total--------
Operating income0-312
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax0-212
Income after tax0-313
Income tax, total0000
Net income0-313
Total adjustments to net income--------
Net income before extra. items0-313
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items0-313
Inc. avail. to common incl. extra. items0-313
Diluted net income0-313
Dilution adjustment--0----
Diluted weighted average shares57565757
Diluted EPS excluding extraordinary itemsvalue per share0.00-0.050.020.04
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.00-0.050.02-0.02